+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

Rabies Immunoglobulins Market - Global Forecast 2025-2030 - Product Thumbnail Image

Rabies Immunoglobulins Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
From
From
Immunoglobulins Market Report 2025 - Product Thumbnail Image

Immunoglobulins Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Intravenous Immunoglobulin Market Report 2025 - Product Thumbnail Image

Intravenous Immunoglobulin Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Dermatomyositis - Pipeline Insight, 2025 - Product Thumbnail Image

Dermatomyositis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Myositis - Pipeline Insight, 2025 - Product Thumbnail Image

Myositis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
From
From
Pharmerging Market - Global Forecast 2024-2030 - Product Thumbnail Image

Pharmerging Market - Global Forecast 2024-2030

  • Report
  • March 2024
  • 191 Pages
  • Global
From
From
Loading Indicator